Vector Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Vector Oncology's estimated annual revenue is currently $6M per year.
- Vector Oncology's estimated revenue per employee is $91,800
Employee Data
- Vector Oncology has 65 Employees.
Vector Oncology's People
| Name | Title | Email/Phone |
|---|
Vector Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $23M | 205 | N/A | N/A | N/A |
#2 | $2.1M | 29 | N/A | N/A | N/A |
#3 | $1.8M | 25 | 4% | N/A | N/A |
#4 | $22.2M | 198 | -3% | N/A | N/A |
#5 | $840.1M | 5883 | 6% | N/A | N/A |
#6 | $6M | 65 | N/A | N/A | N/A |
#7 | $1.9M | 26 | -10% | N/A | N/A |
#8 | $5.3M | 58 | -2% | N/A | N/A |
#9 | $20.2M | 180 | 15% | N/A | N/A |
#10 | $5M | 54 | -25% | N/A | N/A |
What Is Vector Oncology?
Vector Oncology is a leader of oncology specific biopharmaceutical development and commercial outsourcing services. Our novel data repository comprised of aggregated clinical (EMR), patient reported outcomes, genomic, physician notes and billing data powers a broad array of retrospective and prospective HEOR projects that provide an understanding of current practice in oncology care. Vector Oncology also provides comprehensive clinical trial services with specific expertise in supporting and accelerating early phase clinical trials and providing real-world late stage services. All Vector Oncology services are informed by our data repository and medical oncologists who are active members of our team.
keywords:N/A
N/A
Total Funding
65
Number of Employees
$6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vector Oncology News
... in 2019 generated preclinical evidence its AAV vector-encoding modified ... Bayer taps another GSK leader to help shape oncology unit.
Background on oncology companion diagnostics ... Astellas bought for $3 billion in 2019 generated preclinical evidence its AAV vector-encoding modified U7...
The past five years have seen viral-vector-based gene therapies become a ... oncology cell therapies) through ex vivo cell modification.
Other Companies in Memphis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.8M | 65 | 5% | N/A |
#2 | $12.3M | 65 | 5% | N/A |
#3 | $15M | 65 | -13% | N/A |
#4 | $8.8M | 65 | 0% | N/A |
#5 | $15.8M | 65 | 7% | N/A |